Merck & Co Inc
NYSE: MRK
$103.18
+$1.56 (+1.5%)
Real Time Data Delayed 15 Min.
MRK Articles
Monday was a relatively negative day for the markets with all of the major U.S. exchanges pulling back. Crude oil started out flat but came on strong in the afternoon. The S&P 500 sectors were...
Published:
Merck, General Electric, Macy's, and CenturyLink all posted new 52-week lows Monday.
Published:
Last Updated:
Merck, Macy's, General Electric, and 3M all posted new 52-week lows on Monday.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Monday include AMD, Chevron, GM, Intel, Merck, Nokia and Under Armour.
Published:
Last Updated:
Pharma giant Merck reported mixed third-quarter financial results before the markets opened on Friday.
Published:
Last Updated:
The October 13 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
24/7 Wall St. has put together a preview of Boeing, McDonald's, Intel and other top Dow Jones Industrial Average companies due to report their quarterly results this week.
Published:
Last Updated:
These four top companies all have data that could move the shares the rest of this year and into 2018. All have been around for years and will remain sector leaders for years to come.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Wednesday include Chevron, Chipotle Mexican Grill, Exxon Mobil, Goldman Sachs, GoPro, IBM, Merck, Petrobras, UnitedHealth, Visa and...
Published:
Last Updated:
The September 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
U.S. pharmaceutical and biotech stocks may have considerable upside if Credit Suisse's views come to pass. But this part of the market has not come without controversy in the past year and a half.
Published:
Last Updated:
The Dow Jones Industrial Average closed essentially flat on Friday, with Nike and Merck posting the largest losses and Goldman Sachs and Cisco Systems putting up the biggest gains.
Published:
Last Updated:
The September 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
If there is one cure or one treatment that could be the proverbial Holy Grail for a pharmaceutical or biotech company, it would be in a successful treatment of Alzheimer's disease.
Published:
Last Updated:
Apple, UnitedHealth, Walmart, and Merck led the losers among the Dow 30 stocks on Friday.
Published:
Last Updated: